Huang Guo, deputy director of the State Drug Administration of China, said in Beijing on the 5th that the current online sales of pharmaceuticals, medical devices, and cosmetics in China are showing a trend of rapid development. It is estimated that the online sales of drugs and medical devices alone will reach 292.4 billion yuan (RMB, the same below) in 2022, and it is expected to exceed 350 billion yuan in 2023.
On the same day, the Information Office of the State Council of China held a press conference to introduce the situation of China's strengthening of drug supervision. Huang Guo said at the meeting that in order to improve the convenience of online shopping and the quality and safety of online drug sales, the State Food and Drug Administration has planned and adopted a series of measures in advance.
In terms of improving the rule of law, Huang Guo said that the State Food and Drug Administration should promptly establish and improve the legal system in response to new situations and new problems. Up to now, special online sales supervision and management measures have been issued for drugs, medical devices, and cosmetics, mainly clarifying the legal responsibilities of regulatory authorities, operating companies, and third-party platforms, strengthening relevant regulations on online sales monitoring, investigation and handling of discovered cases, emphasizing Relevant measures for safety risk control require strengthening quality management for the entire process of online sales.
In terms of strengthening Internet governance, Huang Guo said that in view of the concealment and divergence of illegal behaviors in online sales, the State Food and Drug Administration has stepped up the establishment of a "network management network" mechanism, and explored the "quick cure" approach , quickly discover and eliminate possible security risks in online sales. "At present, we have implemented full-coverage network monitoring for online sales companies and major third-party platforms, and we will continue to strengthen monitoring in the future to improve the targeting, accuracy and timeliness of monitoring."
In response to the outstanding problems found, the drug regulatory department has successively organized special rectifications on drug online sales, medical device "net cleanup action", cosmetics "online network cleanup and offline source cleanup special action", etc., to investigate and deal with clues in violation of laws and regulations in a timely manner , taking a series of measures such as removing products from shelves, shutting down the network, and canceling filings to continue to purify the online market.
In terms of promoting co-governance, the State Food and Drug Administration has strengthened multi-departmental collaboration, actively promoted linkages with multiple departments such as industry and information technology, network information, health care, and market supervision to form a joint regulatory force; Industry norms guide industry self-discipline.
Huang Guo emphasized that the implementation of platform governance responsibilities by third-party platforms is crucial to improving the quality of online sales and cultivating a good online sales industry ecology. In particular, large-scale platforms must take the lead in implementing platform responsibilities, make full use of their own technical and management advantages, strengthen the legal qualification review and management of settled merchants, strengthen the platform's cooperation obligations in product recalls, risk disposal, and supervision and inspection, and cooperate with Relevant departments do a good job in related work.